|
|
|
FDA Home Page | Dockets Home Page | Dockets
Contacts and Location | Operating Status
| Note:
Many of the documents are in PDF format, and need the Adobe Acrobat
Reader to review the files. Click on the Adobe icon below to download
the free reader. |
|
| Dockets beginning in the year: 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 - 1976 | What's New |
|
| Year
1998 |
|
| Docket Number |
Title of Docket |
| Microbial Effects of Antimicrobial New Animal Drugs Intended for Use in Food-Producing Animals (Updated 9/20/99) |
|
Grated Parmesan Cheese Deviating from Identity Standard (New
6/19/07) |
|
| Effects of Antimicrobial New Animal Drugs Used in Food-Producing Animals (Updated 2/23/00) |
|
| Fast Track Drug Development Programs -- Designation, Application |
|
Prohibition of Cochineal
Extract and Carmine Color Additives (New 6/19/06) |
|
| Convert Allegra/Allegra-D. Claritin/Claritin-D, Zyrtec to OTC (Updated 5/2/01) |
|
| Treatment of Narcotic Dependence (Updated 10/14/05) |
|
Industry on ANDA's: Impurities
in Drug Substances |
|
| Section 114 Health Care Economic Information, FDAMA (Updated 10/28/98) |
|
| Section 122 Radiopharmaceuticals |
|
| Stability Testing of Drug Substances (Updated 10/15/01) |
|
| Section 406b Agency Plan for Statutory Compliance and Annual Report(Updated 2/23/99) |
|
| Over the Counter Human Drugs Labeling Requirements (Updated 4/08/02) |
|
| Review New Drug Applications for Mixtures of Estrogens |
|
| Section 113 NIH Data Bank -Clinical Trials for Serious Diseases (Updated 10/28/98) |
|
| Section 127 Pharmacy Compounding (Updated 11/13/99) |
|
| Section 112 Fast Track Products (Updated 10/13/99) |
|
| Section 121 Positron Emission Tomography (PET) (Updated 10/17/00) |
|
| Section 111 Pediatric Studies of Drugs (Updated 1/26/99) |
|
| Section 118 Data Requirements for Drugs and Biologics (Updated 10/28/9) |
|
| Section 401 Dissemination of Information on Unapproved/New Uses (Updated 10/6/98) |
|
| New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible (New 9/9/02) |
|
| Bulk Drug Substances to be Used in Pharmacy Compounding |
|
| Isomers of Psychotropic Substances: Three Drug Substances (Updated 3/22/99) |
|
| Effects of Dietary Supplements On Structure/Function of Body - Transcript Only(New 8/16/99) |
|
Page updated June 19, 2007 jb
Dockets Home Page | Dockets
Contacts and Location | Operating Status|
Item Code
Definitions | Federal
Register
FDA Home Page | Search FDA
Site | A-Z Index | Contact
FDA | Privacy | Accessibility
Division of Dockets Management